Hair Mesotherapy — INNO-TDS Hair Loss Control

A scalp mesotherapy treatment using INNO-TDS Hair Loss Control — a pharmaceutical-grade cocktail of hair growth factors, vitamins, and follicle-stimulating compounds — delivered via multiple microinjections directly into the scalp dermis. Unlike topical products that struggle to penetrate the scalp barrier, mesotherapy places active ingredients exactly where hair follicles are anchored. At Medianna Clinic, the procedure is performed by experienced medical staff, with the INNO-TDS range representing a clinically validated Spanish pharmaceutical protocol widely used across European dermatology practices for androgenic alopecia and diffuse hair thinning.

Hair loss affecting both men and women involves a combination of androgen sensitivity, microcirculation impairment around the follicle, and progressive miniaturisation of the hair shaft. Topical minoxidil and oral finasteride address only parts of this mechanism; scalp mesotherapy delivers a multi-target intervention directly to the dermal papilla — the control centre of the hair follicle — bypassing the barrier that limits topical treatments. Medianna Clinic uses the INNO-TDS Hair Loss Control cocktail, manufactured by InnoEsthetics (Spain) under pharmaceutical GMP standards. The Hair Loss Control formulation is specifically indicated for androgenic alopecia (pattern hair loss) and contains: DHT-blocker compounds (including saw palmetto extract and azelaic acid) to counteract dihydrotestosterone-mediated follicle miniaturisation, vasodilating agents (including adenosine and caffeine derivatives) to improve microcirculation around the follicular unit, growth-stimulating peptides and amino acids that support keratinocyte proliferation in the dermal papilla, and B vitamins and zinc as essential cofactors for follicle metabolism and keratin production. **Session protocol:** A physician or trained nurse examines the scalp to map areas of thinning and confirm the hair loss pattern. The scalp is cleansed, and a topical numbing solution may be applied for comfort. The INNO-TDS cocktail is loaded into a fine-gauge mesotherapy gun or manual needles and delivered via multiple small injections (nappage technique) across the thinning zones at 1–2 cm spacing. Total needle contact time is roughly 15–20 minutes; the rest of the appointment is preparation and post-procedure care. **Expected results:** Initial improvements in scalp health and reduced shedding are typically seen after 2–3 sessions. Visible new hair growth and improved density generally appear after session 4–6, as the follicular cycle responds. Hair growth is a slow process — full assessment of a protocol's impact takes 3–6 months. **Recommended course:** 4–6 sessions at 2–4 week intervals for the induction phase, followed by quarterly maintenance sessions. **Preparation:** Wash hair on the day of the appointment but do not apply any styling products. Avoid aspirin or ibuprofen for 48 hours prior (reduces bruising risk). **Aftercare:** Avoid washing hair for 24 hours post-procedure. Skip intense sport and sauna for 48 hours. Mild redness and pinpoint marks on the scalp are normal and resolve within 24 hours. **Safety:** Not suitable during pregnancy or active scalp infection. Inform the physician of any blood-thinning medications or autoimmune conditions.